The Galntl5 Polyclonal Antibody (PACO09406) is a valuable tool for researchers studying Galntl5, an important enzyme involved in protein glycosylation and cell surface modifications. This antibody, produced in rabbits, exhibits high specificity and sensitivity towards Galntl5 in human samples, making it an excellent choice for use in Western blot applications. By targeting the Galntl5 protein, this antibody enables accurate detection and analysis in various cell types, providing researchers with valuable insights into cellular glycosylation processes.
Galntl5 is a key player in protein glycosylation pathways, impacting various biological processes such as cell signaling, cell adhesion, and immune response modulation. Dysregulation of Galntl5 has been linked to diseases like cancer, cardiovascular disorders, and neurodegenerative diseases, making it a promising target for therapeutic interventions. By studying the function of Galntl5, researchers can gain a better understanding of its role in disease pathogenesis and potentially identify new strategies for treatment development.
